Ulteriori informazioni
"The fourth volume in Stahl's Case Studies series describing the approach, diagnosis, and treatment of children and adolescents with psychiatric disorders. Demonstrating core principles that allow clinicians to individualize treatment and engage families, creating the best outcomes. Essential reading for mental health professionals and students"--
Sommario
Introduction; List of icons; Abbreviations; 1. The case: the salutatorian who couldn't speak: Selective Serotonin Reuptake Inhibitor (SSRI)-refractory anxiety in an adolescent; 2. The case: from anxious to activated: Selective Serotonin Reuptake Inhibitor (SSRI)-related activation; 3. The case: the girl who couldn't sleep: Posttraumatic Stress Disorder (PTSD) in a young girl; 4. The case: depressed and still depressed: Major Depressive Disorder (MDD) in an adolescent; 5. The case: a 13-year-old adolescent who feels 'amazing': Selective Serotonin Reuptake Inhibitor (SSRI)-induced mania in an adolescent; 6. The case: counting on a cure: Obsessive-Compulsive Disorder (OCD) in an adolescent; 7. The case: struggles in the second grade: Attention-Deficit Hyperactivity Disorder (ADHD) in a child; 8. The case: from prodrome to psychosis: early-onset schizophrenia; 9. The case: too much, too little, or just right? lithium dosing in an adolescent; 10. The case: tic, tic, tic: motor and vocal tics in a boy; 11. The case: how slow can you go? Selective Serotonin Reuptake Inhibitor (SSRI) withdrawal and discontinuation in an adolescent; 12. The case: the adolescent who doesn't eat: anorexia nervosa in an adolescent; 13. The case: high or higher antidepressant concentrations? cannabis-related drug interactions in an adolescent; 14. The case: the boy whose bed was always wet: nocturnal enuresis in a child; 15. The case: counting sheep and counting treatment trials: insomnia disorder in an adolescent; 16. The case: Second-Generation Antipsychotics (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with Autism Spectrum Disorder (ASD); 17. The case: the 'standard treatment' is earning a 'D': treatment-resistant schizophrenia; 18. The case: symptoms, side effects, or both? Selective Serotonin Reuptake Inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent; Index.
Info autore
Jeffrey R. Strawn, MD is Professor of Psychiatry & Behavioral Neuroscience in the College of Medicine, University of Cincinnati, Cincinnati, Ohio.Stephen M. Stahl, MD is Adjunct Professor of Psychiatry at the University of California, San Diego, Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge. He is also Clinical Professor of Psychiatry in Norton College of Medicine at Upstate Medical University.
